Clin2
NCT07247162Possibly a fitNot yet recruiting

Osilodrostat for high blood pressure in Cushing's syndrome

HypertensionHypercortisolemiaCushing Syndrome

Treatments studied

Part of Cancer, Heart & circulation, Hormones & metabolism clinical trials.

This study tests a drug called osilodrostat (a pill) to see if it can lower blood pressure in people with Cushing's syndrome. If you have Cushing's and your blood pressure is still high despite medication, this trial might help you find better control.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
63 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old
  • You must have a confirmed diagnosis of Cushing's syndrome
  • Your blood pressure must be higher than normal (average 135/85 or more) despite taking blood pressure medications
  • You must not have taken certain Cushing's treatments recently (varies by drug, from 1 week to 3 months)
  • You must be able to take oral medication and follow the study requirements

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03708900Recruiting· Phase 2
Osilodrostat study for children with Cushing’s syndrome

This Phase 2 study tests how osilodrostat works in children and teens with Cushing’s syndrome—what the drug does in the body, how it affects hormones, and how safely it’s tolerated. It may help families who cannot have immediate surgery or whose surgery has already failed or is still pending.

San Francisco, California
NCT05521529Recruiting
Study of Cushing’s symptoms before and after treatment

This study looks at how Cushing’s syndrome affects people before treatment and what changes after treatment. It may help researchers understand what to expect and improve care for adults with newly diagnosed Cushing’s syndrome.

Aarhus, State
NCT06801249Recruiting· Phase 4
Metyrapone for heart risk in adrenal tumors with Cushing's

This trial tests if a drug called Metyrapone can lower heart risks in people who have adrenal nodules (noncancerous growths on the adrenal glands) and a mild form of Cushing's syndrome that doesn't cause obvious physical signs. You'll be given the drug and monitored to see if it helps control blood pressure and other heart risk factors.

Bologna
NCT07748975Not yet recruiting
Study of a blood pressure hormone and a silencing treatment

This trial looks at how a natural hormone called aldosterone (which helps control blood pressure) and a treatment that silences it affect people with high blood pressure. It aims to find better ways to manage high blood pressure by studying real patient data.

Vadhana, Bangkok
NCT07090161Recruiting· Phase 2
Study of iloperidone for uncontrolled high blood pressure

This trial tests if iloperidone can lower blood pressure in people whose high blood pressure is not controlled by current medications. You may qualify if your blood pressure is still high after weeks of treatment.

Phoenix, Arizona
NCT03364803Recruiting
Sharing treatment results for people with Cushing’s syndrome

This is a study that collects and reviews information about how people with Cushing’s syndrome (including some mild forms and certain “silent” tumors) are diagnosed and treated, and what outcomes they have. It may help researchers understand which treatments work best in different types of the condition.

Basking Ridge, New Jersey

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.